A pragmatic trial for the fracture of old age
A hip fracture in an elderly person is sometimes called "the last fracture of life" — and as populations age, its burden keeps growing. Pain that is poorly controlled after surgery is linked to complications such as blood clots and delirium, and older patients tolerate opioid medication poorly. Better pain control with fewer opioids is therefore a genuine clinical problem, not a comfort issue.
A randomised trial led by Li Ting's trauma team at Beijing Jishuitan Hospital, published in The Journal of Bone & Joint Surgery (JBJS), tested one addition to standard care: infiltrating the surgical wound with liposomal bupivacaine, a long-acting local anaesthetic formulation.
What was done
The prospective, randomised, double-blind, parallel-group trial enrolled 76 patients undergoing surgery for a geriatric hip fracture, with a median age of 77 years. All patients received a standardised multimodal analgesia pathway — intravenous patient-controlled analgesia plus a pre-operative fascia iliaca block. Half additionally received liposomal bupivacaine wound infiltration; half did not. The primary endpoint was resting pain at 48 hours after surgery.
Resting pain at 48 hours did not differ between groups — the addition did not meet its primary endpoint. However, the liposomal bupivacaine group reported less resting pain at 24 hours, better pain control during movement at several time points, less oral rescue medication, higher patient satisfaction, and better sleep on the first night after surgery (longer and better-quality sleep). No local-anaesthetic systemic toxicity occurred in either group.
How to read a negative primary endpoint
The investigators reported the miss plainly, which is exactly what a reader should want. A 76-patient trial is small, and absence of a difference on one endpoint is not proof of no value: the secondary findings on movement pain, medication use and sleep are consistent with a real but modest effect that matters to recovering patients. The study's own conclusion is measured — the strategy "remains of clinical value for further exploration" — and it adds Chinese-trial evidence to a question international guidelines still debate.
The ERAS context behind the trial
The trial sits inside a larger programme. Beijing Jishuitan Hospital introduced ERAS (enhanced recovery after surgery) principles into trauma orthopaedics in 2015 and built a co-managed pathway for elderly hip fracture patients. According to the hospital's account, average time from admission to surgery has fallen from 7 days to within 48 hours, and in-hospital mortality from 1.7% to 0.1%, with tens of thousands of elderly patients treated.
Relevance to elderly hip fracture care
For international families arranging surgery for an elderly relative, post-operative pain management and early recovery are among the most common concerns. This summary belongs to Wellward China's Bones, Joints, Spine & Muscles and Injuries, Burns & Trauma health areas. It describes research evidence, not a treatment plan for any individual patient.